meta|evidence oncology
  • Living systematic review and meta-analysis
 
  • metastatic/advanced RCC (mRCC) - 2nd line (L2) 2
  • sarcomas
  • thyroid cancer
  • urothelial cancer (UC) - bladder cancer (BC)